0001849739-26-000014.txt : 20260706 0001849739-26-000014.hdr.sgml : 20260706 20260706202529 ACCESSION NUMBER: 0001849739-26-000014 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260701 FILED AS OF DATE: 20260706 DATE AS OF CHANGE: 20260706 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Selecky Christobel CENTRAL INDEX KEY: 0001849739 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37507 FILM NUMBER: 261157576 MAIL ADDRESS: STREET 1: C/O IMMUNITYBIO, INC. STREET 2: 3530 JOHN HOPKINS COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ImmunityBio, Inc. CENTRAL INDEX KEY: 0001326110 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 431979754 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3530 JOHN HOPKINS COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (844) 696-5235 MAIL ADDRESS: STREET 1: 3530 JOHN HOPKINS COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: NantKwest, Inc. DATE OF NAME CHANGE: 20150713 FORMER COMPANY: FORMER CONFORMED NAME: Conkwest, Inc. DATE OF NAME CHANGE: 20140416 FORMER COMPANY: FORMER CONFORMED NAME: ZelleRx Corp DATE OF NAME CHANGE: 20050504 4 1 wk-form4_1783383927.xml FORM 4 X0609 4 2026-07-01 0 0001326110 ImmunityBio, Inc. IBRX 0001849739 Selecky Christobel false C/O IMMUNITYBIO, INC. 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 1 0 0 0 1 Common Stock 2026-07-01 4 M 0 35064 2.98 A 35064 D Common Stock 2026-07-01 4 M 0 124414 2.99 A 159478 D Common Stock 2026-07-01 4 S 0 159478 9.0236 D 0 D Stock Option (right to buy) 2.98 2026-07-01 4 M 0 35064 0 D 2023-06-12 2032-06-14 Common Stock 35064 0 D Stock Option (right to buy) 2.99 2026-07-01 4 M 0 124414 0 D 2024-06-10 2033-06-13 Common Stock 124414 0 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. Represents the weighted average share price of an aggregate total of 159,478 shares sold in the price range of $9.00 to $9.07 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, ImmunityBio, Inc. (the "Issuer") or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. /s/ Philip LoScalzo, as Attorney-in-Fact 2026-07-06